Paul R. Young

ORCID: 0000-0002-2040-5190

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial”.

Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial

The Lancet Infectious Diseases(2021)10.1016/s1473-3099(21)00200-0

N/A

4.1DataRank · unranked

121 citations

Francesca L. Mordant, Zheyi Li, Danushka K. Wijesundara, Paula Ellenberg, Julia Lackenby +30 more

Polygenic risk scores are associated with atrial electrophysiologic substrate abnormalities and outcomes after atrial fibrillation catheter ablation

Heart Rhythm(2023)10.1016/j.hrthm.2023.02.011

N/A

0.345DataRank · unranked

9 citations

G. Wong, Paul R. Young, David Chieng, Joshua Hawson, Robert D. Anderson +16 more

Deaths in Children and Adolescents Associated With COVID-19 and MIS-C in the United States

PEDIATRICS(2021)10.1542/peds.2021-052273

N/A

0DataRank · unranked

93 citations

LaTonia C. Richardson, Paul R. Young, Laura Viens, Carolyn V. Gould, Anne Kimball +40 more

The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

UNC Libraries(2020)10.17615/57ks-d095

N/A

0DataRank · unranked

1 citations

L. Varani, Michael Diamond, Stephen S. Whitehead, Erika Navarro-Sánchez, Annalisa Macagno +12 more

A platform technology for generating subunit vaccines against diverse viral pathogens

Frontiers in Immunology(2022)10.3389/fimmu.2022.963023

N/A

0DataRank · unranked

25 citations

Ariel Isaacs, Connor A. P. Scott, Naphak Modhiran, Christopher L. D. McMillan, Stacey T. M. Cheung +15 more

Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients with urothelial carcinoma.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.509

N/A

0DataRank · unranked

8 citations

Bradley C. Leibovich, Tanner Miest, Stephen Bardot, Paul R. Young, Stephen A. Boorjian +14 more

Retroviral integrations contribute to elevated host cancer rates during germline invasion

Nature Communications(2021)10.1038/s41467-021-21612-7

N/A

0DataRank · unranked

47 citations

David E. Alquezar‐Planas, Anisha Dayaram, Amber Gillett, Rachael Tarlinton, Nigel P. Mongan +8 more

Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients undergoing radical cystectomy (RC) for urothelial carcinoma but ineligible for neoadjuvant cisplatin-based chemotherapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps3172

N/A

0DataRank · unranked

1 citations

Tanner Miest, Paul R. Young, Mark L. Gonzalgo, Stephen A. Boorjian, Matthew K. Tollefson +15 more